Review

April 15, 2022


Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, et al.
Clin Mol Hepatol. 2023;29(1):1-15.

Review

June 9, 2022


Management of refractory ascites
Florence Wong
Clin Mol Hepatol. 2023;29(1):16-32.

Review

July 4, 2022


Wnt signaling in liver regeneration, disease, and cancer
Gengyi Zou, Jae-Il Park
Clin Mol Hepatol. 2023;29(1):33-50.

Review

July 29, 2022


Development and prognosis of hepatocellular carcinoma in patients with diabetes
Takuma Nakatsuka, Ryosuke Tateishi
Clin Mol Hepatol. 2023;29(1):51-64.

Review

August 12, 2022


Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment
Soo-Jeung Park, Young S. Hahn
Clin Mol Hepatol. 2023;29(1):65-76.

Review

October 13, 2022


Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
Clin Mol Hepatol. 2023;29(1):77-98.

Original Article

August 12, 2022


Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
Young Eun Chon, Seong Yong Park, Han Pyo Hong, et al.
Clin Mol Hepatol. 2023;29(1):120-134.

Original Article

September 5, 2022


Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
Yu Jun Wong, Chen Zhaojin, Guilia Tosetti, et al.
Clin Mol Hepatol. 2023;29(1):135-145.

Original Article

August 19, 2022


Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
Lung-Yi Mak, Danny Wong, Alison Kuchta, et al.
Clin Mol Hepatol. 2023;29(1):146-162.


Review
1671
Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller
Clin Mol Hepatol. 2023;29(1):1-15.   Published online April 15, 2022
View: 5536   Download: 86
1684
Management of refractory ascites
Florence Wong
Clin Mol Hepatol. 2023;29(1):16-32.   Published online June 9, 2022
View: 1773   Download: 323
1691
Wnt signaling in liver regeneration, disease, and cancer
Gengyi Zou, Jae-Il Park
Clin Mol Hepatol. 2023;29(1):33-50.   Published online July 4, 2022
View: 1583   Download: 128
1696
Development and prognosis of hepatocellular carcinoma in patients with diabetes
Takuma Nakatsuka, Ryosuke Tateishi
Clin Mol Hepatol. 2023;29(1):51-64.   Published online July 29, 2022
View: 1342   Download: 131  Citations: 2
1699
Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment
Soo-Jeung Park, Young S. Hahn
Clin Mol Hepatol. 2023;29(1):65-76.   Published online August 12, 2022
View: 1440   Download: 103  Citations: 2
1714
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
Clin Mol Hepatol. 2023;29(1):77-98.   Published online October 13, 2022
View: 1583   Download: 266
Editorial
The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol. 2023;29(1):99-101.   Published online October 27, 2022
View: 602   Download: 31
The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
Jeong-Ju Yoo, Sang Gyune Kim
Clin Mol Hepatol. 2023;29(1):102-104.   Published online November 10, 2022
View: 552   Download: 69
1730
Non-invasive tests-based risk stratification: Baveno VII and beyond
Georg Semmler, Mathias Jachs, Mattias Mandorfer
Clin Mol Hepatol. 2023;29(1):105-109.   Published online November 23, 2022
View: 586   Download: 45  Citation: 1
Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
Susana G Rodrigues
Clin Mol Hepatol. 2023;29(1):110-112.   Published online December 12, 2022
View: 514   Download: 36
Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
Clin Mol Hepatol. 2023;29(1):113-117.   Published online October 31, 2022
View: 638   Download: 45  Citation: 1
New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
Young-Suk Lim
Clin Mol Hepatol. 2023;29(1):118-119.   Published online November 29, 2022
View: 418   Download: 56
Original Article
1698
Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
Young Eun Chon, Seong Yong Park, Han Pyo Hong, Donghee Son, Jonghyun Lee, Eileen Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun
Clin Mol Hepatol. 2023;29(1):120-134.   Published online August 12, 2022
View: 1039   Download: 97  Citations: 2
1703
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
Yu Jun Wong, Chen Zhaojin, Guilia Tosetti, Elisabetta Degasperi, Sanchit Sharma, Samagra Agarwal, Liu Chuan, Chan Yiong Huak, Li Jia, Qi Xiaolong, Anoop Saraya, Massimo Primignani
Clin Mol Hepatol. 2023;29(1):135-145.   Published online September 5, 2022
View: 1461   Download: 181  Citations: 4
1700
Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
Lung-Yi Mak, Danny Wong, Alison Kuchta, Martina Hilfiker, Aaron Hamilton, Ning Chow, XianHua Mao, Wai Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2023;29(1):146-162.   Published online August 19, 2022
View: 1123   Download: 144  Citations: 3
Letter to the Editor
Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
Yuanbin Liu, Mingkai Chen
Clin Mol Hepatol. 2023;29(1):163-164.   Published online October 27, 2022
View: 611   Download: 36
Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
Do Seon Song, U Im Chang, Jin Mo Yang
Clin Mol Hepatol. 2023;29(1):165-167.   Published online October 31, 2022
View: 661   Download: 37  Citation: 1
Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Clin Mol Hepatol. 2023;29(1):168.   Published online October 31, 2022
View: 731   Download: 39  Citation: 1
Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
Clin Mol Hepatol. 2023;29(1):173-175.   Published online November 15, 2022
View: 418   Download: 21
Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen
Clin Mol Hepatol. 2023;29(1):176-178.   Published online November 10, 2022
View: 494   Download: 33
Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Clin Mol Hepatol. 2023;29(1):179-181.   Published online November 22, 2022
View: 402   Download: 24
Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Clin Mol Hepatol. 2023;29(1):185-187.   Published online November 10, 2022
View: 421   Download: 15
Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani
Clin Mol Hepatol. 2023;29(1):188-190.   Published online November 22, 2022
View: 498   Download: 31
Snapshot
1750
Epidemiology and updated management for autoimmune liver disease
Nae-Yun Heo, Haeryoung Kim
Clin Mol Hepatol. 2023;29(1):194-196.   Published online December 14, 2022
View: 518   Download: 41

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

  • PubMed Central
  • PubMed
  • Scopus
  • KoreaMed
  • KoMCI
  • ScienceCentral
  • DOAJ
  • GoogleScholar
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • Metadata
  • ORCID
  • MeSH on Demand
  • COPE
  • EMBASE
  • KOFST
  • ICMJE
  • Web of SCIENCE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1360
TOTAL : 1128482
Close layer